| 000 | 01716 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516083315.0 | ||
| 264 | 0 | _c20121126 | |
| 008 | 201211s 0 0 eng d | ||
| 022 | _a1742-7843 | ||
| 024 | 7 |
_a10.1111/j.1742-7843.2012.00880.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBatcioglu, Kadir | |
| 245 | 0 | 0 |
_aOxidative stress in the in vivo DMBA rat model of breast cancer: suppression by a voltage-gated sodium channel inhibitor (RS100642). _h[electronic resource] |
| 260 |
_bBasic & clinical pharmacology & toxicology _cAug 2012 |
||
| 300 |
_a137-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a9,10-Dimethyl-1,2-benzanthracene _xtoxicity |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlutathione Peroxidase _xgenetics |
| 650 | 0 | 4 |
_aMalondialdehyde _xmetabolism |
| 650 | 0 | 4 |
_aMammary Neoplasms, Experimental _xchemically induced |
| 650 | 0 | 4 |
_aMexiletine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aSodium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aSuperoxide Dismutase _xgenetics |
| 700 | 1 | _aUyumlu, A Burcin | |
| 700 | 1 | _aSatilmis, Basri | |
| 700 | 1 | _aYildirim, Battal | |
| 700 | 1 | _aYucel, Neslihan | |
| 700 | 1 | _aDemirtas, Hakan | |
| 700 | 1 | _aOnkal, Rustem | |
| 700 | 1 | _aGuzel, R Mine | |
| 700 | 1 | _aDjamgoz, Mustafa B A | |
| 773 | 0 |
_tBasic & clinical pharmacology & toxicology _gvol. 111 _gno. 2 _gp. 137-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1742-7843.2012.00880.x _zAvailable from publisher's website |
| 999 |
_c21634076 _d21634076 |
||